Articles related to VISION/OCULAR HEALTH

A 23-year-old woman with bilateral blurry vision, floaters, and a history of premature birth presented with exudative retinopathy and vascular features overlapping multiple inherited and acquired retinal disorders.

Bayer agreed to acquire Perfuse Therapeutics in a deal valued at up to $2.45 billion, gaining full rights to a phase 2 endothelin receptor antagonist for glaucoma and diabetic retinopathy.

Early trials suggest red‑light therapy may slow pediatric myopia progression, but unanswered questions around long‑term retinal safety and clinical positioning remain.

Alcon’s Clareon TruPlus adds an enhanced monofocal option aimed at improving intermediate vision while preserving distance quality, with real‑world outcomes yet to be defined.

“In discussions with ophthalmologists and optometrists, nearly all say they would choose SLT first if it were their own eye. However, when asked how often their patients receive SLT as initial therapy, most report rates around 10%.” – John Berdahl, MD, Vance Thompson Vision

“When screen time reaches this level, regular eyecare becomes essential, not optional.” — Valerie Sheety-Pilon, OD, VSP Vision Care SVP of Clinical and Medical Affairs